Literature DB >> 12052192

Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.

Milt Teitler1, Katharine Herrick-Davis, Anil Purohit.   

Abstract

Several lines of evidence indicate that G-protein coupled receptors (GPCR) may exist in a state that allows a tonic level of stimulation in vivo (constitutive activity). Several native forms of GPCR, when expressed in recombinant cell lines, display significant signal transduction stimulation in the absence of activating ligand. Many GPCR, including three serotonin receptors, display robust constitutive activation upon the mutation of a single amino acid, indicating mutations producing inappropriate constitutive activation may be etiological factors in diseases. If constitutive activity of GPCR is as common a phenomenon as some researchers suspect, this would suggest significant alterations in the classical model of ligand-receptor interactions. One of the most significant implications of constitutive activity for pharmacologists and medicinal chemists, is the possibility of developing drugs that lower the level of constitutive activity. Such compounds have been termed inverse agonists . These drugs, in theory, would have different physiological effects, and therefore possibly different therapeutic potential, than classical competitive receptor antagonists ( neutral antagonists ). Theoretical issues concerning constitutive activity in the GPCR family and some of the evidence supporting the existence of constitutive activity in the GPCR family is reviewed. Studies are presented demonstrating the procedures for producing and characterizing constitutive activated forms of serotonin receptors, including the demonstration of inverse agonist activity of drugs on these receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052192     DOI: 10.2174/1568026023393859

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  10 in total

1.  Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Authors:  Anil Purohit; Carol Smith; Katharine Herrick-Davis; Milt Teitler
Journal:  Psychopharmacology (Berl)       Date:  2004-12-10       Impact factor: 4.530

2.  Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Authors:  Laura C Sullivan; William P Clarke; Kelly A Berg
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  Ligand-induced activation of ERK1/2 signaling by constitutively active Gs-coupled 5-HT receptors.

Authors:  Ping Liu; Yu-Ling Yin; Ting Wang; Li Hou; Xiao-Xi Wang; Man Wang; Guan-Guan Zhao; Yi Shi; H Eric Xu; Yi Jiang
Journal:  Acta Pharmacol Sin       Date:  2019-03-04       Impact factor: 6.150

Review 4.  Mechanisms of gut microbiota-mediated bone remodeling.

Authors:  Jing Yan; Ayumi Takakura; Kambiz Zandi-Nejad; Julia F Charles
Journal:  Gut Microbes       Date:  2017-09-29

5.  Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background.

Authors:  Andrzej Slominski; Przemyslaw M Plonka; Alexander Pisarchik; James L Smart; Virginie Tolle; Jacobo Wortsman; Malcolm J Low
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

6.  Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.

Authors:  Gonzalo Romero; Elisabeth Sánchez; Marta Pujol; Pilar Pérez; Xavier Codony; Jörg Holenz; Helmut Buschmann; Petrus J Pauwels
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

7.  The serotonin type 3A receptor facilitates luteinizing hormone release and LHbeta promoter activity in immortalized pituitary gonadotropes.

Authors:  Phillip L Quirk; Ruth E Siegel
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

8.  Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

Authors:  Małgorzata Dukat; Philip D Mosier; Renata Kolanos; Bryan L Roth; Richard A Glennon
Journal:  J Med Chem       Date:  2008-01-18       Impact factor: 7.446

9.  Structural insights into the lipid and ligand regulation of serotonin receptors.

Authors:  Peiyu Xu; Sijie Huang; Huibing Zhang; Chunyou Mao; X Edward Zhou; Xi Cheng; Icaro A Simon; Dan-Dan Shen; Hsin-Yung Yen; Carol V Robinson; Kasper Harpsøe; Bo Svensson; Jia Guo; Hualiang Jiang; David E Gloriam; Karsten Melcher; Yi Jiang; Yan Zhang; H Eric Xu
Journal:  Nature       Date:  2021-03-24       Impact factor: 49.962

Review 10.  Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System.

Authors:  Kate Z Peters; Joseph F Cheer; Raffaella Tonini
Journal:  Trends Neurosci       Date:  2021-03-03       Impact factor: 16.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.